Bioniz
VerifiedBiotechnology company focused on discovering small peptides and molecules for the treatment of autoimmune diseases and cancer
Launch date
Employees
Ownership
Firm valuation
$329m (Dealroom.co estimates Feb 2022.)
Irvine Industrial Complex-East United States (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - Not yet verified | |
| $599k | Seed | ||
| N/A | $718k | Seed Not yet verified | |
| $13m | Series A | ||
| N/A | Acquisition | ||
* | $329m Valuation: $329m | Acquisition | |
| Total Funding | $13.6m | ||
Recent News about Bioniz
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.